Literature DB >> 16487163

Neuropathic pain is enhanced in delta-opioid receptor knockout mice.

Xavier Nadal1, Josep-Eladi Baños, Brigitte L Kieffer, Rafael Maldonado.   

Abstract

We have evaluated the possible involvement of delta-opioid receptor (DOR) in the development and expression of neuropathic pain. For this purpose, partial ligation of the sciatic nerve was performed in DOR knockout mice and wild-type littermates. The development of mechanical and thermal allodynia, as well as thermal hyperalgesia was evaluated by using the von Frey filament model, the cold-plate test and the plantar test, respectively. In wild-type and DOR knockout mice, sciatic nerve injury led to a neuropathic pain syndrome revealed in these nociceptive behavioural tests. However, the development of mechanical and thermal allodynia, and thermal hyperalgesia was significantly enhanced in DOR knockout mice. These results reveal the involvement of DOR in the control of neuropathic pain and suggest a new potential therapeutic use of DOR agonists.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16487163     DOI: 10.1111/j.1460-9568.2006.04569.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  54 in total

Review 1.  Ligand-directed signalling within the opioid receptor family.

Authors:  Amynah A Pradhan; Monique L Smith; Brigitte L Kieffer; Christopher J Evans
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

Review 2.  Delta opioid receptor analgesia: recent contributions from pharmacology and molecular approaches.

Authors:  Claire Gavériaux-Ruff; Brigitte Lina Kieffer
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

Review 3.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

4.  The mixed kappa and delta opioid receptor agonist, MP1104, attenuates chemotherapy-induced neuropathic pain.

Authors:  Diana Vivian Atigari; Kelly Frances Paton; Rajendra Uprety; András Váradi; Amy Frances Alder; Brittany Scouller; John H Miller; Susruta Majumdar; Bronwyn Maree Kivell
Journal:  Neuropharmacology       Date:  2020-12-28       Impact factor: 5.250

5.  Interaction between δ opioid receptors and benzodiazepines in CO₂-induced respiratory responses in mice.

Authors:  Anne H Borkowski; Dylan C Barnes; Derek R Blanchette; F Xavier Castellanos; Donald F Klein; Donald A Wilson
Journal:  Brain Res       Date:  2011-04-28       Impact factor: 3.252

6.  Plasma membrane cholesterol level and agonist-induced internalization of δ-opioid receptors; colocalization study with intracellular membrane markers of Rab family.

Authors:  Jana Brejchova; Miroslava Vosahlikova; Lenka Roubalova; Marco Parenti; Mario Mauri; Oleksandr Chernyavskiy; Petr Svoboda
Journal:  J Bioenerg Biomembr       Date:  2016-07-13       Impact factor: 2.945

Review 7.  Alleviating pain with delta opioid receptor agonists: evidence from experimental models.

Authors:  Sophie Berthiaume; Khaled Abdallah; Véronique Blais; Louis Gendron
Journal:  J Neural Transm (Vienna)       Date:  2020-03-18       Impact factor: 3.575

Review 8.  Panic, suffocation false alarms, separation anxiety and endogenous opioids.

Authors:  Maurice Preter; Donald F Klein
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-08-09       Impact factor: 5.067

9.  Mu-opioid receptors are not necessary for nortriptyline treatment of neuropathic allodynia.

Authors:  Yohann Bohren; Dzenan Karavelic; Luc-Henri Tessier; Ipek Yalcin; Claire Gavériaux-Ruff; Brigitte L Kieffer; Marie-José Freund-Mercier; Michel Barrot
Journal:  Eur J Pain       Date:  2009-12-28       Impact factor: 3.931

Review 10.  The delta opioid receptor tool box.

Authors:  Ana Vicente-Sanchez; Laura Segura; Amynah A Pradhan
Journal:  Neuroscience       Date:  2016-06-24       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.